Mind the gap in kidney care: translating what we know into what we do.


Journal

Jornal brasileiro de nefrologia
ISSN: 2175-8239
Titre abrégé: J Bras Nefrol
Pays: Brazil
ID NLM: 9426946

Informations de publication

Date de publication:
2024
Historique:
received: 25 10 2023
accepted: 01 12 2023
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 11 7 2024
Statut: epublish

Résumé

Historically, it takes an average of 17 years for new treatments to move from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. Now is the time to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions are diagnosed worldwide, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because it is often silent in the early stages. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from the patient to the clinician to the health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.

Identifiants

pubmed: 38991207
pii: S0101-28002024000300201
doi: 10.1590/2175-8239-JBN-2024-E007en
pii:
doi:

Types de publication

Journal Article Editorial

Langues

eng por

Sous-ensembles de citation

IM

Pagination

e2024E007

Références

Kidney Med. 2022 Aug 24;4(10):100540
pubmed: 36185707
Pediatr Nephrol. 2022 Dec;37(12):2997-3008
pubmed: 35286452
Semin Nephrol. 2022 Sep;42(5):151315
pubmed: 37001337
Indian J Pediatr. 2017 Nov;84(11):822-825
pubmed: 28711960
Semin Nephrol. 2017 May;37(3):234-244
pubmed: 28532553
BMC Med Ethics. 2022 Apr 27;23(1):47
pubmed: 35477488
Diabetes Obes Metab. 2023 Nov;25(11):3327-3336
pubmed: 37580309
BMC Health Serv Res. 2022 Apr 26;22(1):560
pubmed: 35473928
Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e007264
pubmed: 33176463
Nephrol Dial Transplant. 2023 May 4;38(5):1260-1270
pubmed: 36301617
Kidney Int. 2024 Apr;105(4S):S117-S314
pubmed: 38490803
Kidney Int Rep. 2020 Oct 16;5(12):2246-2255
pubmed: 33305118
JAMA Cardiol. 2019 Oct 1;4(10):978-986
pubmed: 31461123
J Diabetes. 2023 Mar;15(3):224-236
pubmed: 36889912
Kidney Int Rep. 2020 Apr 21;5(6):920-923
pubmed: 32518875
Adv Chronic Kidney Dis. 2021 Jul;28(4):318-327
pubmed: 34922688
Lancet. 2022 Nov 19;400(10365):1788-1801
pubmed: 36351458
Am J Kidney Dis. 2023 Dec;82(6):677-686
pubmed: 37516297
JMIR Form Res. 2022 Sep 28;6(9):e40001
pubmed: 36170008
Eur Heart J. 2022 Feb 10;43(6):474-484
pubmed: 35023547
BMJ Glob Health. 2023 Jun;6(Suppl 3):
pubmed: 37344004
Am J Kidney Dis. 2017 Sep;70(3):337-346
pubmed: 28366517
Clin Kidney J. 2023 Sep 13;16(Suppl 1):i12-i19
pubmed: 37711639
Lancet Glob Health. 2016 May;4(5):e307-19
pubmed: 27102194
JAMA Netw Open. 2019 Dec 2;2(12):e1918169
pubmed: 31860111
J Healthc Leadersh. 2023 Jul 03;15:103-119
pubmed: 37416849
Lancet. 2016 Jan 2;387(10013):61-9
pubmed: 26498706
Diabetes Obes Metab. 2023 Oct;25(10):2970-2979
pubmed: 37395334
Kidney Int. 2022 Nov;102(5):969-973
pubmed: 36044940
Lancet. 2019 Aug 24;394(10199):652-662
pubmed: 31327566
Am J Kidney Dis. 2020 Nov;76(5):636-644
pubmed: 32682696
Lancet. 2023 Apr 15;401(10384):1302-1312
pubmed: 36931289
BMC Nephrol. 2022 Jan 5;23(1):17
pubmed: 34986789
Clin Kidney J. 2023 Jun 16;16(8):1187-1198
pubmed: 37529652
JAMA. 2023 Apr 25;329(16):1333-1336
pubmed: 37018006
Bull World Health Organ. 2018 Jun 1;96(6):414-422D
pubmed: 29904224
Kidney Int Rep. 2020 Dec 17;6(2):437-448
pubmed: 33615069
Can J Diabetes. 2022 Jul;46(5):464-472
pubmed: 35739044
Nat Rev Nephrol. 2023 Nov;19(11):694-708
pubmed: 37580571
J Manag Care Spec Pharm. 2023 May;29(5):449-463
pubmed: 37121255
Kidney Int. 2022 Nov;102(5S):S1-S127
pubmed: 36272764
Health Serv Insights. 2021 Jul 28;14:11786329211036011
pubmed: 34376990
Cochrane Database Syst Rev. 2019 Aug 06;8:CD012379
pubmed: 31425608
Pediatr Nephrol. 2024 Jan;39(1):193-201
pubmed: 37488241
PLoS One. 2022 Oct 14;17(10):e0266617
pubmed: 36240220
J Gen Intern Med. 2023 Jan;38(1):147-155
pubmed: 35776372
Clin J Am Soc Nephrol. 2023 Nov 1;18(11):1408-1415
pubmed: 37550842
Nat Rev Nephrol. 2017 Jul;13(7):393-409
pubmed: 28555652
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Global Health. 2015 Nov 10;11:43
pubmed: 26555199
Kidney Int. 2019 Nov;96(5):1048-1050
pubmed: 31582227
Kidney Int. 2023 Apr;103(4):772-781
pubmed: 36738891
Lancet. 2018 Nov 17;392(10160):2203-2212
pubmed: 30195398
Lancet. 2017 Oct 21;390(10105):1888-1917
pubmed: 28434650
Health Sci Rep. 2023 Jan 14;6(1):e1064
pubmed: 36660259
Clin J Am Soc Nephrol. 2022 Jul;17(7):1092-1103
pubmed: 35649722
Kidney Med. 2021 Jun 01;3(4):576-585.e1
pubmed: 34401725
Kidney Int. 2021 Mar;99(3S):S1-S87
pubmed: 33637192
Eur Heart J. 2023 Jun 9;44(22):1970-1972
pubmed: 37042346

Auteurs

Valerie A Luyckx (VA)

University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Zurich, Switzerland.
Harvard Medical School, Brigham and Women's Hospital, Department of Medicine, Renal Division, Boston, Massachusetts, USA.
University of Cape Town, Department of Paediatrics and Child Health, Cape Town, South Africa.

Katherine R Tuttle (KR)

Providence Inland Northwest Health, Providence Medical Research Center, Spokane, Washington, USA.
University of Washington, Department of Medicine, Nephrology Division, Seattle, Washington, USA.

Dina Abdellatif (D)

Cairo University Hospital, Department of Nephrology, Cairo, Egypt.

Ricardo Correa-Rotter (R)

National Medical Science and Nutrition Institute Salvador Zubiran, Department of Nephrology and Mineral Metabolism, Mexico City, Mexico.

Winston W S Fung (WWS)

University of Hong Kong, Prince of Wales Hospital, Department of Medicine and Therapeutics, The Chinese Shatin, Hong Kong, China.

Agnès Haris (A)

Péterfy Hospital, Nephrology Department, Budapest, Hungary.

Li-Li Hsiao (LL)

Harvard Medical School, Brigham and Women's Hospital, Department of Medicine, Renal Division, Boston, Massachusetts, USA.

Makram Khalife (M)

ISN Patient Liaison Advisory Group, Brussel, Belgium.

Latha A Kumaraswami (LA)

Tamilnad Kidney Research (TANKER) Foundation, Chennai, India.

Fiona Loud (F)

ISN Patient Liaison Advisory Group, Brussel, Belgium.

Vasundhara Raghavan (V)

ISN Patient Liaison Advisory Group, Brussel, Belgium.

Stefanos Roumeliotis (S)

Aristotle University of Thessaloniki, AHEPA University Hospital Medical School, 2nd Department of Nephrology, Thessaloniki, Greece.

Marianella Sierra (M)

ISN Patient Liaison Advisory Group, Brussel, Belgium.

Ifeoma Ulasi (I)

University of Nigeria, College of Medicine, Department of Medicine, Ituku-Ozalla, Enugu, Nigeria.

Bill Wang (B)

ISN Patient Liaison Advisory Group, Brussel, Belgium.

Siu-Fai Lui (SF)

The Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, Division of Health System, Policy and Management, Hong Kong, China.

Vassilios Liakopoulos (V)

Aristotle University of Thessaloniki, AHEPA University Hospital Medical School, 2nd Department of Nephrology, Thessaloniki, Greece.

Alessandro Balducci (A)

Italian Kidney Foundation, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH